MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Making Progress for Myelodysplastic Syndrome

July 25th 2017, 7:15pm

Article

In an interview with CURE, Rami Komrokji, M.D., a hematologist at Moffitt Cancer Center in Tampa, Florida, discusses the advances that have been made in MDS in the past few years, as well as the MDS Clinical Research Consortium and its importance.

The Roller Coaster of MDS

July 14th 2017, 7:09am

Article

MDS is a rare form of cancer with its own unique characteristics. Here is one patients perspective on the experience of having MDS.

Filling an Unmet Need in MDS Treatment

July 7th 2017, 7:25pm

Video

Rami S. Komrokji, M.D., clinical director of Hematologic Malignancies at Moffitt Cancer Center, discusses an unmet need in the treatment of myelodysplastic syndrome (MDS).

Younger Patients With AML and MDS Best Suited for Intensive Preparatory Regimen Before Stem Cell Transplant

July 7th 2017, 6:49pm

Article

An intensive preparatory stem cell transplant (SCT) regimen should be used for younger patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS), according to the results of a phase 3 clinical trial.

FDA Approves Tool for Blood Cancer Detection

June 30th 2017, 5:51pm

Article

ClearLLab multicolor reagents (T1, T2, B1, B2, M) gained approval from the Food and Drug Administration (FDA) to detect chronic leukemia, acute leukemia, non-Hodgkin lymphoma, multiple myeloma, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN). This is the first approval the agency received for immunophenotyping on a flow cytometer.

The Wonder of the Oncology Nurse

May 31st 2017, 5:40am

Article

What do oncology nurses mean to their patients? This is an inside view from one grateful patient.

Being Vulnerable With Cancer Is OK

February 7th 2017, 9:51pm

Article

Exploring a Promising Option for Low-Risk MDS

December 22nd 2016, 9:04pm

Article

Revlimid is showing promise for patients with low-risk MDS, according to the results of a recent study.

Higher Cost Does Not Improve Overall Survival in Elderly Patients with MDS

May 24th 2016, 9:07pm

Article

High cost does not always mean better chances of survival for elderly patients with MDS, according to a recent study.

Jason R. Gotlib on JAK Inhibitors for the Treatment of Myelofibrosis

March 23rd 2016, 12:48am

Video

Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.